2019 Qaab Cusub 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1

Waayo-aragnimada maamulka mashaariicda ee aad u badan iyo hal ilaa hal nooc oo gaar ah ayaa ka dhigaya muhiimadda weyn ee isgaarsiinta ururka iyo fahamkayaga fudud ee rajooyinkaaga 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, waxay diyaar u yihiin inay ku siiyaan qiimaha ugu hooseeya ee suuqa, tayada ugu fiican iyo adeegga iibka aad u fiican. Ku soo dhawoow inaad nala sameyso bussines, aynu noqono laba guulood.
Mashruucyada aadka u badan ee khibradaha maamulka iyo hal ilaa hal nooc oo bixiye gaar ah ayaa ka dhigaya muhiimada la taaban karo ee isgaarsiinta ururka iyo fahamkayaga fudud ee waxyaabaha aad ka filanaysoShiinaha 3-Aminopyrazine-2-Carboxylic Acid iyo 5424-01-1, Alaabtayadu aad bay caan ugu yihiin ereyga, sida Koonfurta Ameerika, Afrika, Aasiya iyo wixii la mid ah.Shirkadaha si ay "u abuuraan badeecooyin heerka koowaad ah" sida hadafka, oo ay ku dadaalaan inay macaamiisha siiyaan xalal tayo sare leh, bixiyaan adeeg tayo sare leh ka dib iibka iyo taageerada farsamada, iyo faa'iidada wadaagga macaamiisha, abuuraan xirfad iyo mustaqbal wanaagsan!

2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid waxaa loo isticmaalaa dhexdhexaadinta Eltrombopag.
Eltrombopag, oo ay soo saartay GlaxoSmithKline (GSK) ee UK oo markii dambe si wadajir ah ula sameeyay Novartis ee Switzerland, waa kan ugu horreeya oo kaliya ee la ansixiyay molecule yar yar oo aan peptide TPO receptor agonist ee adduunka.Eltrombopag waxaa ansixiyay US FDA 2008 si loogu daweeyo idiopathic thrombocytopenic purpura (ITP), iyo 2014 ee daawaynta aplastic anemia daran (AA).Sidoo kale waa dawadii ugu horeysay ee ay ogolaato FDA US daawaynta AA 30kii sano ee la soo dhaafay.
Bishii Disembar 2012, US FDA waxay ansixisay Eltrombopag daaweynta thrombocytopenia ee bukaannada qaba cagaarshow C dabadheeraad ah (CHC), si bukaannada cagaarshowga C ee qaba saadaasha liidata sababtoo ah tirinta platelet hoose waxay bilaabi karaan oo ay ilaalin karaan interferon ku salaysan daaweynta caadiga ah ee cudurada beerka.Febraayo 3,2014, GlaxoSmithKline waxay ku dhawaaqday in FDA ay siisay shahaadada daawaynta dawaynta ee Eltrombopag ee daawaynta hemopenia ee bukaanada qaba buuga kiimikada daran aplastic anemia (SAA) kuwaas oo aan si buuxda uga jawaabin tallaalka.Agoosto 24, 2015, US FDA waxay ansixisay Eltrombopag daawaynta thrombocytopenia ee dadka waaweyn iyo carruurta da'doodu tahay 1 sano iyo ka weyn ee leh difaaca joogtada ah ee thrombocytopenia (ITP) kuwaas oo aan lahayn jawaab celin ku filan corticosteroids, immunoglobulins ama splenectomy.Janaayo 4, 2018, Eltrombopag waxaa loo ogolaaday in lagu daro Shiinaha si loogu daaweeyo trombocytopenia difaaca aasaasiga ah (ITP).

Waayo-aragnimada maamulka mashaariicda ee aad u badan iyo hal ilaa hal nooc oo gaar ah ayaa ka dhigaya muhiimadda weyn ee isgaarsiinta ururka iyo fahamkayaga fudud ee rajooyinkaaga 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, waxay diyaar u yihiin inay ku siiyaan qiimaha ugu hooseeya ee suuqa, tayada ugu fiican iyo adeegga iibka aad u fiican. Ku soo dhawoow inaad nala sameyso bussines, aynu noqono laba guulood.
2019 CusubShiinaha 3-Aminopyrazine-2-Carboxylic Acid iyo 5424-01-1, Alaabtayadu aad bay caan ugu yihiin ereyga, sida Koonfurta Ameerika, Afrika, Aasiya iyo wixii la mid ah.Shirkadaha si ay "u abuuraan badeecooyin heerka koowaad ah" sida hadafka, oo ay ku dadaalaan inay macaamiisha siiyaan xalal tayo sare leh, bixiyaan adeeg tayo sare leh ka dib iibka iyo taageerada farsamada, iyo faa'iidada wadaagga macaamiisha, abuuraan xirfad iyo mustaqbal wanaagsan!